Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning (pages 202–210)Mehdi Hamadani, Michael Craig, Gary S. Phillips, Jame Abraham, William Tse, Aaron Cumpston, Laura Gibson, Scot C. Remick, Pamela Bunner, Sonia Leadmon, Patrick Elder, Craig Hofmeister, Sam Penza, Yvonne Efebera, Leslie Andritsos, Ramiro Garzon, Don M. Benson Jr., William Blum and Steven M. Devine
Article first published online: 28 FEB 2011 | DOI: 10.1002/hon.985